Ranexa (ranolozaine)

By Business Review Editor

Pharma Deals Review: Vol 2006 Issue 71 (Table of Contents)

Published: 6 May-2006

DOI: 10.3833/pdr.v2006.i71.513     ISSN: 1756-7874

Section: Deal Trackers



Ranolazine (piperazine acetamide) is a partial fatty acid oxidation (pFOX) inhibitor and represents a new class of metabolic inhibitors for the treatment of chronic stable angina (CSA)...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details